BATS BZX Real-Time Price
As of 3:39pm ET
| -0.03 / -0.41%|
The 4 analysts offering 12-month price forecasts for Protagonist Therapeutics Inc have a median target of 15.00, with a high estimate of 18.00 and a low estimate of 11.00. The median estimate represents a +104.92% increase from the last price of 7.32.
The current consensus among 4 polled investment analysts is to Buy stock in Protagonist Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.